Phosphodiesterase - Immune System Research

Rolipram is a Selective Phosphodiesterases PDE4 Inhibitor

Edward Jenner 2021-12-03

Phosphodiesterases (PDEs) are enzymes that convert cyclic nucleotides (cAMP and cGMP) to their corresponding 5′-AMP and 5′-GMP in order to inactivate the cyclic nucleotides. There are currently 11 members in…

Inflammation

OR-1896, a Levosimendan Metabolite and Powerful Vasodilator, is a Potent Calcium Sensitiser

Edward Jenner 2020-03-03

Calcium sensitizer agents are a class of inotropic agents in the treatment of decompensated heart failure. Levosimendan is a short half-life calcium sensitizer used as pharmacological inotropic support in acute…

Rolipram is a Selective Phosphodiesterases PDE4 Inhibitor

OR-1896, a Levosimendan Metabolite and Powerful Vasodilator, is a Potent Calcium Sensitiser

You Missed

Remibrutinib is an Orally Active BTK Inhibitor for Chronic Urticaria Research

Taurolidine is a Broad-spectrum Antimicrobial for Central Venous Catheter-Related Infections Research

Cabergoline is a D2-like Receptor Agonist for High Prolactin Levels Related Diseases

Ondansetron is a 5-HT3 Receptor Antagonist for Anti-inflammation Research